PharmaBoardroom

180-Day Exclusivity: The Key Ingredient in Hatch-Waxman

The AAM's Chip Davis looks back on 35 years of healthcare system savings from generic pharmaceuticals in the US, and the peril the generics industry…

Amendments to Russia’s Pharma Labeling Legislation: Uncertainty…

Nadezhda Fedotova and Andrey Zelenin of Lidings law firm gives an update on recent amendments to the labeling legislation for medicines in Russia,…

Egis: Holding On To Hungarian Heritage

Established in Hungary in 1913, Egis is a traditional Central Eastern European pharmaceutical company with an international footprint across the…

Gábor Orbán – CEO, Gedeon Richter

Gábor Orbán, CEO of Gedeon Richter, highlights the recent turnaround of the company's performance, its exciting new collaboration with Allergan in…

Rae Yuan – President, Sinovant Sciences, China

Rae Yuan, president of Sinovant Sciences, shares the company’s “transformer” strategy culminating in a strong pipeline of innovative products…

Hans P Schmid – Chairman & Enrico Magnani – General…

Hans Schmid, chairman; and Enrico Magnani, GM, of global cancer supportive care leader Helsinn Pharmaceuticals’ operations in China, share the Swiss…

Irma Veberic – General Manager, Roche Hungary

Irma Veberic, general manager of Roche Hungary, gives her insights on the key issues being faced by the Hungarian healthcare system and the…

Three More Key Issues for Pharma: Regulatory Assertiveness,…

Eurasia Group’s Aditya Bhattacharji tackles three more key geopolitical issues that global pharma needs to be cognizant of: the world’s leading…

The UAE’s Fight Against Genetic Diseases

With a relatively high number of genetic disorders, the Arab population of the United Arab Emirates (UAE) is increasingly becoming the subject of new…

István Hodász – CEO, Egis

István Hodász, CEO of Egis Pharmaceuticals PLC, introduces the longstanding history of the company and its positioning as a leading manufacturer of…

Dajun Yang – Chairman, Executive Director & CEO,…

Speaking in May 2019, Dr Dajun Yang, chairman, executive director and CEO of Ascentage Pharma, shares the company’s top highlights over the past…

Peter Bauer – Managing Director, Bioinova, Czech Republic

Bioinova’s CEO and managing director MUDr Peter Bauer PhD introduces the biotech company’s shift from a university spin-off to a privately held…

Tagged with EG